No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Induction chemotherapy with cisplatin plus gemcitabine in addition to concurrent chemotherapy improves survival for nasopharyngeal carcinoma

byTeddy Guo

September 20, 2022

in StudyGraphics

Reading Time: 1 min read

Click to read this study in the Journal of Clinical Oncology.

RELATED REPORTS

#VisualAbstract: Tarlatamab Improves Survival in Small-Cell Lung Cancer after Platinum-Based Chemotherapy

2 Minute Medicine: Pharma Roundup – Perioperative Immunotherapy Efficacy, Expanded Prostate Cancer Indication, Rapid Subcutaneous Myeloma Administration, and Regulatory Compliance Findings [June 4 2025]

Sotorasib plus panitumumab may be a promising treatment option for colorectal cancer

Combination avelumab and axitinib treatment of advanced type B3 thymoma and thymic carcinoma is promising as second-line treatment after standard therapy.

RelatedReports

StudyGraphics

#VisualAbstract: Tarlatamab Improves Survival in Small-Cell Lung Cancer after Platinum-Based Chemotherapy

June 19, 2025

Pharma

2 Minute Medicine: Pharma Roundup – Perioperative Immunotherapy Efficacy, Expanded Prostate Cancer Indication, Rapid Subcutaneous Myeloma Administration, and Regulatory Compliance Findings [June 4 2025]

June 4, 2025

Benefits of high-intensity surveillance following colorectal adenoma removal likely outweigh costs

Gastroenterology

Sotorasib plus panitumumab may be a promising treatment option for colorectal cancer

April 16, 2025

StudyGraphics

#VisualAbstract: Adjuvant PD-1 Blockade With Camrelizumab Improves Survival in Nasopharyngeal Carcinoma

March 26, 2025

Parental input in oncology-related palliation and pain relief for children [Classics Series]

Gender conformity influences use of laxatives and muscle-building products

Risk of myopathy and myalgia among statin users may be small and clinically insignificant

Remote patient monitoring did not reduce heart failure readmissions: The BEAT-HF trial

Impact on socioeconomic status with HFrEF outcomes

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result